Trial: 202002183

A phase II pilot trial to estimate survival after a non-total body irradiation (TBI) based conditioning regimen in patients diagnosed with B-acute lymphoblastic leukemia (ALL) who are pre-allogeneic hematopoietic cell transplantation (HCT) next-generation-sequence (NGS) minimal residual disease (MRD) negative



Principal Investigator

Bhatt, Sima

Disease Site

Lymphoid Leukemia

Learn more about this study at: